Royal Bank of Canada’s Intermolecular, Inc. IMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-2
Closed 7413
2019
Q1
$0 Hold
2
﹤0.01% 7306
2018
Q4
$0 Hold
2
﹤0.01% 7423
2018
Q3
$0 Buy
+2
New +$3 ﹤0.01% 7141
2018
Q2
Sell
-19
Closed 6948
2018
Q1
$0 Hold
19
﹤0.01% 7079
2017
Q4
$0 Hold
19
﹤0.01% 7152
2017
Q3
$0 Buy
+19
New +$18 ﹤0.01% 7169
2015
Q4
Sell
-12
Closed 6964
2015
Q3
$0 Buy
+12
New +$25 ﹤0.01% 6872
2014
Q4
Sell
-100
Closed 6384
2014
Q3
$0 Hold
100
﹤0.01% 6223
2014
Q2
$0 Hold
100
﹤0.01% 6243
2014
Q1
$0 Hold
100
﹤0.01% 6250
2013
Q4
$0 Sell
100
-203
-67% -$1.15K ﹤0.01% 6273
2013
Q3
$2K Buy
303
+203
+203% +$1.28K ﹤0.01% 5890
2013
Q2
$1K Buy
+100
New +$851 ﹤0.01% 5756

Other funds holding IMI

Royal Bank of Canada's IMI Position: Q2 2019 in Review

Royal Bank of Canada sold out of Intermolecular, Inc. (IMI) in Q2 2019, closing a stake of 2 shares.

Royal Bank of Canada first reported a position in IMI in Q2 2013 and held it in 13 quarters. The position peaked at $2K in Q3 2013. 40 funds tracked by Wall St. Rank hold IMI as of Q2 2019.

  • Royal Bank of Canada reported no remaining Intermolecular, Inc. position as of Q2 2019 after selling out during the quarter.
  • Royal Bank of Canada sold 2 Intermolecular, Inc. shares in Q2 2019.
  • Royal Bank of Canada first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 13 quarters.
  • Royal Bank of Canada's Intermolecular, Inc. position peaked at $2K in Q3 2013.
  • 40 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q2 2019.

Based on Royal Bank of Canada's 13F filing for Q2 2019, filed 14 Aug 2019.